0001213900-24-025519.txt : 20240325
0001213900-24-025519.hdr.sgml : 20240325
20240325160133
ACCESSION NUMBER: 0001213900-24-025519
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230829
FILED AS OF DATE: 20240325
DATE AS OF CHANGE: 20240325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Louria Hayon Igal
CENTRAL INDEX KEY: 0001903781
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53002
FILM NUMBER: 24779142
MAIL ADDRESS:
STREET 1: 4 LUI PASTER
CITY: TEL AVIV-JAFFA
STATE: L3
ZIP: 6803605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Raphael Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001415397
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 260204284
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 105 - 5348 VEGAS DR.
CITY: LAS VEGAS
STATE: NV
ZIP: 89108
BUSINESS PHONE: 702-442-1166
MAIL ADDRESS:
STREET 1: SUITE 105 - 5348 VEGAS DR.
CITY: LAS VEGAS
STATE: NV
ZIP: 89108
FORMER COMPANY:
FORMER CONFORMED NAME: Easy Energy Inc
DATE OF NAME CHANGE: 20071017
4
1
ownership.xml
X0508
4
2023-08-29
0
0001415397
Raphael Pharmaceutical Inc.
RAPH
0001903781
Louria Hayon Igal
4 LUI PASTER
TEL AVIV-JAFFA
L3
6803605
ISRAEL
1
1
0
0
Chief Technology Officer
0
Common Stock
2023-08-29
4
X
0
999000
0.01
A
999000
D
Warrants to purchase Common Stock
0.01
2023-08-29
2023-08-29
4
X
0
999000
D
2022-12-05
2024-07-05
Common Stock
999000
0
D
The transaction reported is an exercise of warrants to purchase common stock. In accordance with General Instruction 4(c)(iii), the exercise price is reported under column 2 of this table.
/s/ Igal Louria Hayon
2024-03-25